查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600646

计算生物学市场：按服务、应用和最终用途分类 - 全球预测 2025-2030

Computational Biology Market by Services (Contract, In-house), Application (Cellular Biological Simulation, Clinical Trials, Drug Discovery & Disease Modelling), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年计算生物学市场规模为62.5亿美元，预计2024年将达到74.2亿美元，复合年增长率为18.91%，到2030年将达到210.1亿美元。

计算生物学是一个跨学科领域，汇集了生物学、电脑科学、物理学和数学的力量来模拟和建模生物系统。它有助于管理和分析各种生物学研究（包括基因组学、蛋白质组学和系统生物学）产生的大量资料。对计算生物学的需求源于其加速药物发现、个人化医疗和提高对复杂生物过程的理解的能力。计算生物学的应用涵盖药物发现、疾病建模和农业生物技术，影响製药、医疗保健和农业等最终用途领域。计算生物学市场在很大程度上受到技术进步、研发投资的增加以及预测建模工具的日益采用的推动。然而，由于健康问题和个人化治疗需求的增加，潜在的成长机会在于生物资讯学在临床诊断和癌症基因组学领域的扩展。公司应专注于开发整合运算平台并增强机器学习演算法，以提高发现和预测能力。儘管前景乐观，但市场面临着工具和软体成本高、生物系统复杂性以及对资料安全性的担忧等挑战，这些可能会降低采用率。克服这些障碍需要加强跨部门协作、改进资料整合方法以及对具有成本效益的解决方案的投资。潜在的创新领域包括合成生物学、CRISPR 技术的进步以及基因组编辑和蛋白质结构预测的人工智慧应用。在这些创新领域处于领先地位可以为业务成长带来巨大好处。市场竞争激烈，发展迅速，企业不断追求突破，以提高生物研究的精确度和效率。能够应对这些挑战并有效利用创新的公司将处于有利地位，能够占领重要的市场占有率。

主要市场统计
基准年[2023] 62.5亿美元
预测年份 [2024] 74.2亿美元
预测年份 [2030] 210.1亿美元
复合年增长率（%） 18.91%

市场动态：揭示快速发展的计算生物学市场的关键市场洞察

供需的动态交互作用正在改变计算生物学市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对个人化医疗的需求不断增长
    • 扩大生物资讯学研究并增加临床研究
    • 在癌症治疗中应用计算生物学
  • 市场限制因素
    • 缺乏熟练的专业人员来操作计算工具
  • 市场机会
    • 加速生物资讯学和多尺度生物建模在细胞建模的应用
    • 增加对生物资讯学的资助和计算生物学领域的进步
  • 市场挑战
    • 缺乏互通性和多平台功能以及缺乏明确的标准

波特五力：驾驭运算生物学市场的策略工具

波特的五力框架是了解计算生物学市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解计算生物学市场的外部影响

外部宏观环境因素在塑造计算生物学市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解计算生物学市场的竞争格局

计算生物学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵计算生物学市场供应商的绩效评估

FPNV 定位矩阵是评估计算生物学市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对个人化医疗的需求不断增长
      • 生物资讯学研究的进展和临床研究的增加
      • 在肿瘤治疗中采用计算生物学
    • 抑制因素
      • 缺乏熟练的专业人员来操作计算工具
    • 机会
      • 加速生物资讯学和多尺度生物建模在细胞建模的应用
      • 增加对生物资讯学的资助和计算生物学领域的进步
    • 任务
      • 缺乏互通性和多平台功能以及缺乏明确定义的标准
  • 市场区隔分析
    • 服务：受益于敏感资料和专有研究的内部计算生物学能力
    • 应用：计算生物学在简化药物开发平臺的重要应用
    • 最终用途：商业组织越来越多地采用计算生物学来应对应用研究挑战
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第六章计算生物学市场：依服务分类

  • 合约
  • 公司内部

第七章计算生物学市场：依应用分类

  • 细胞生物模拟
  • 临床试验
  • 药物发现与疾病建模
  • 人体模拟软体
  • 临床前药物开发

第八章计算生物学市场：依最终用途

  • 学术的
  • 商业的

第九章美洲计算生物学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区计算生物学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的计算生物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 为年轻的加拿大研究人员提供新的资金，以在生物资讯学、计算生物学和健康资料科学领域建立职业生涯
    • Pluto 宣布获得由 Silverton Partners主导的 370 万美元种子轮融资
    • Accenture投资 Ocean Genomics 加速人工智慧药物发现和个人化医疗开发

公司名单

  • Thermo Fisher Scientific Inc.
  • SOPHiA GENETICS
  • Eurofins Scientific SE
  • Chemical Computing Group Inc.
  • Nimbus Discovery Llc
  • Simulation Plus Inc.
  • Instem Group
  • Ocean Genomics
  • DNASTAR, Inc.
  • Waters Corporation
  • DNAnexus, Inc.
  • Rosa & Co. Llc
  • BGI Group
  • Dassault Systemes SE
  • Biomax Informatics AG
  • PerkinElmer, Inc.
  • ProFound Therapeutics
  • Insilico Medicine
  • WuXi NextCODE
  • Genedata AG
  • Schrodinger, Inc.
  • QIAGEN NV
  • Agilent Technologies, Inc.
  • Pluto Bioinformatics
  • Illumina, Inc.
  • Compugen Ltd.
Product Code: MRR-433AB1DC289D

The Computational Biology Market was valued at USD 6.25 billion in 2023, expected to reach USD 7.42 billion in 2024, and is projected to grow at a CAGR of 18.91%, to USD 21.01 billion by 2030.

Computational Biology is a multidisciplinary field that combines the power of biology, computer science, physics, and mathematics to simulate and model biological systems. Its scope includes genomics, proteomics, and systems biology, facilitating the management and analysis of the vast data generated through various biological research. The necessity of computational biology arises from its ability to accelerate drug discovery, personalize medicine, and enhance our understanding of complex biological processes. Its applications span across drug design, disease modeling, and agricultural biotechnology, influencing end-use sectors such as pharmaceuticals, healthcare, and agriculture. The market for computational biology is significantly driven by technological advancements, increasing investments in R&D, and a rise in the adoption of predictive modeling tools. However, potential growth opportunities lie in the expansion of bioinformatics in clinical diagnostics and cancer genomics due to increasing health concerns and the demand for personalized treatments. Companies should focus on developing integrated computational platforms and enhancing machine learning algorithms to boost discovery and predictive capabilities. Despite promising prospects, the market faces challenges such as high costs of tools and software, the complexity of biological systems, and data security concerns, which could slow down adoption rates. Overcoming these hurdles involves increasing cross-disciplinary collaborations, improving data integration methods, and investing in cost-effective solutions. Potential areas of innovation include advancements in synthetic biology, CRISPR technology, and artificial intelligence applications for genome editing and protein structure prediction. For business growth, staying ahead in these innovation fields could provide significant advantages. The nature of the computational biology market is competitive yet rapidly evolving, with players continually seeking breakthroughs to enhance precision and efficiency in biological research. Companies that address these challenges and leverage their innovations effectively are well-placed to capture significant market share.

KEY MARKET STATISTICS
Base Year [2023] USD 6.25 billion
Estimated Year [2024] USD 7.42 billion
Forecast Year [2030] USD 21.01 billion
CAGR (%) 18.91%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Computational Biology Market

The Computational Biology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Need for Personalized Medicine
    • Growing Bioinformatics Research and Increasing Number of Clinical Studies
    • Adoption of Computational Biology in Oncology Therapeutics
  • Market Restraints
    • Dearth of Skilled Professionals to Operate Computational Tools
  • Market Opportunities
    • Accelerating Use of Bioinformatics and Multiscale Biological Modeling in Cell Modeling
    • Increased Funding in Bioinformatics Coupled with Advancements in the Field of Computational Biology
  • Market Challenges
    • Insufficiency of Interoperability and Multiplatform Capabilities and Lack of Well-Defined Standards

Porter's Five Forces: A Strategic Tool for Navigating the Computational Biology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Computational Biology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Computational Biology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Computational Biology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Computational Biology Market

A detailed market share analysis in the Computational Biology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Computational Biology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Computational Biology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Computational Biology Market, highlighting leading vendors and their innovative profiles. These include Thermo Fisher Scientific Inc., SOPHiA GENETICS, Eurofins Scientific SE, Chemical Computing Group Inc., Nimbus Discovery Llc, Simulation Plus Inc., Instem Group, Ocean Genomics, DNASTAR, Inc., Waters Corporation, DNAnexus, Inc., Rosa & Co. Llc, BGI Group, Dassault Systemes SE, Biomax Informatics AG, PerkinElmer, Inc., ProFound Therapeutics, Insilico Medicine, WuXi NextCODE, Genedata AG, Schrodinger, Inc., QIAGEN N.V., Agilent Technologies, Inc., Pluto Bioinformatics, Illumina, Inc., and Compugen Ltd..

Market Segmentation & Coverage

This research report categorizes the Computational Biology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Services, market is studied across Contract and In-house.
  • Based on Application, market is studied across Cellular Biological Simulation, Clinical Trials, Drug Discovery & Disease Modelling, Human Body Simulation Software, and Preclinical Drug Development.
  • Based on End-Use, market is studied across Academics and Commercial.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Need for Personalized Medicine
      • 5.1.1.2. Growing Bioinformatics Research and Increasing Number of Clinical Studies
      • 5.1.1.3. Adoption of Computational Biology in Oncology Therapeutics
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of Skilled Professionals to Operate Computational Tools
    • 5.1.3. Opportunities
      • 5.1.3.1. Accelerating Use of Bioinformatics and Multiscale Biological Modeling in Cell Modeling
      • 5.1.3.2. Increased Funding in Bioinformatics Coupled with Advancements in the Field of Computational Biology
    • 5.1.4. Challenges
      • 5.1.4.1. Insufficiency of Interoperability and Multiplatform Capabilities and Lack of Well-Defined Standards
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Benefits of in-house computational biology capabilities to handle sensitive data or proprietary research
    • 5.2.2. Application: Significant applications of computational biology to streamline the drug development pipeline
    • 5.2.3. End-Use: Growing adoption of computational biology in commercial entities to tackle applied research challenges
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Computational Biology Market, by Services

  • 6.1. Introduction
  • 6.2. Contract
  • 6.3. In-house

7. Computational Biology Market, by Application

  • 7.1. Introduction
  • 7.2. Cellular Biological Simulation
  • 7.3. Clinical Trials
  • 7.4. Drug Discovery & Disease Modelling
  • 7.5. Human Body Simulation Software
  • 7.6. Preclinical Drug Development

8. Computational Biology Market, by End-Use

  • 8.1. Introduction
  • 8.2. Academics
  • 8.3. Commercial

9. Americas Computational Biology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Computational Biology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Computational Biology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. New Funds Available for Early Career Canadian Researchers Building Careers in Bioinformatics, Computational Biology, or Health Data Sciences
    • 12.3.2. Pluto Announces USD 3.7M Seed Round, Led by Silverton Partners
    • 12.3.3. Accenture Invests in Ocean Genomics to Accelerate AI-driven Drug Discovery and the Development of Personalized Medicines

Companies Mentioned

  • 1. Thermo Fisher Scientific Inc.
  • 2. SOPHiA GENETICS
  • 3. Eurofins Scientific SE
  • 4. Chemical Computing Group Inc.
  • 5. Nimbus Discovery Llc
  • 6. Simulation Plus Inc.
  • 7. Instem Group
  • 8. Ocean Genomics
  • 9. DNASTAR, Inc.
  • 10. Waters Corporation
  • 11. DNAnexus, Inc.
  • 12. Rosa & Co. Llc
  • 13. BGI Group
  • 14. Dassault Systemes SE
  • 15. Biomax Informatics AG
  • 16. PerkinElmer, Inc.
  • 17. ProFound Therapeutics
  • 18. Insilico Medicine
  • 19. WuXi NextCODE
  • 20. Genedata AG
  • 21. Schrodinger, Inc.
  • 22. QIAGEN N.V.
  • 23. Agilent Technologies, Inc.
  • 24. Pluto Bioinformatics
  • 25. Illumina, Inc.
  • 26. Compugen Ltd.

LIST OF FIGURES

  • FIGURE 1. COMPUTATIONAL BIOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. COMPUTATIONAL BIOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. COMPUTATIONAL BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. COMPUTATIONAL BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMPUTATIONAL BIOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COMPUTATIONAL BIOLOGY MARKET DYNAMICS
  • TABLE 7. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CONTRACT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CELLULAR BIOLOGICAL SIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY DRUG DISCOVERY & DISEASE MODELLING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY HUMAN BODY SIMULATION SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY PRECLINICAL DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY ACADEMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COMPUTATIONAL BIOLOGY MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM COMPUTATIONAL BIOLOGY MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. COMPUTATIONAL BIOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. COMPUTATIONAL BIOLOGY MARKET, FPNV POSITIONING MATRIX, 2023